Y. Chen, C. Hu, and Y. Wang. Biostatistics (Oxford, England), 7 (4):
515-29(October 2006)5077<m:linebreak></m:linebreak>JID: 100897327; 2006/02/14 aheadofprint; ppublish;<m:linebreak></m:linebreak>Risc atribuïble.
Y. Wang, L. Meyerson, Y. Tang, and N. Qian. Journal of the neurological sciences, 285 (1-2):
206-11(October 2009)5489<m:linebreak></m:linebreak>JID: 0375403; 0 (Antibodies, Monoclonal); 0 (Immunologic Factors); 0 (natalizumab); 2009/03/05 received; 2009/07/15 revised; 2009/07/22 accepted; 2009/08/25 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de dades; Count data.
R. Chappell. Clinical cancer research : an official journal of the American Association for Cancer Research, 18 (8):
2127-9(April 2012)6822<m:linebreak></m:linebreak>CI: (c)2012; JID: 9502500; CON: Clin Cancer Res. 2012 Apr 15;18(8):2301-8. PMID: 22282466; 2012/03/16 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència; Competing risks.
B. Miladinovic, A. Kumar, R. Mhaskar, S. Kim, R. Schonwetter, and B. Djulbegovic. PloS one, 7 (10):
e47804(January 2012)6965<m:linebreak></m:linebreak>JID: 101285081; 2012/05/11 received; 2012/09/21 accepted; 2012/10/17 epublish; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència; Avaluació de riscs.
K. Leffondré, K. Jager, J. Boucquemont, V. Stel, and G. Heinze. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 29 (10):
1806-14(October 2014)Anàlisi de dades; Nefrologia; Introductori.